164 related articles for article (PubMed ID: 32648179)
1. Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies.
Leick KM; Kazarian AG; Rajput M; Tomanek-Chalkley A; Miller A; Shrader HR; McCarthy A; Coleman KL; Kasi PM; Chan CHF
Ann Surg Oncol; 2020 Dec; 27(13):5065-5071. PubMed ID: 32648179
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
[TBL] [Abstract][Full Text] [Related]
3. Detection of
Michaelidou K; Koutoulaki C; Mavridis K; Vorrias E; Papadaki MA; Koutsopoulos AV; Mavroudis D; Agelaki S
Cells; 2020 Nov; 9(11):. PubMed ID: 33233668
[No Abstract] [Full Text] [Related]
4.
Wang ZY; Ding XQ; Zhu H; Wang RX; Pan XR; Tong JH
Front Oncol; 2019; 9():1295. PubMed ID: 31850201
[No Abstract] [Full Text] [Related]
5. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
[TBL] [Abstract][Full Text] [Related]
6. KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.
Olmedillas López S; García-Olmo DC; García-Arranz M; Guadalajara H; Pastor C; García-Olmo D
Int J Mol Sci; 2016 Apr; 17(4):484. PubMed ID: 27043547
[TBL] [Abstract][Full Text] [Related]
7. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
Sugimori M; Sugimori K; Tsuchiya H; Suzuki Y; Tsuyuki S; Kaneta Y; Hirotani A; Sanga K; Tozuka Y; Komiyama S; Sato T; Tezuka S; Goda Y; Irie K; Miwa H; Miura Y; Ishii T; Kaneko T; Nagahama M; Shibata W; Nozaki A; Maeda S
Cancer Sci; 2020 Jan; 111(1):266-278. PubMed ID: 31746520
[TBL] [Abstract][Full Text] [Related]
8. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Clinical Cutoff Value for Multiplex KRAS
Lee KH; Lee TH; Choi MK; Kwon IS; Bae GE; Yeo MK
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708359
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
[TBL] [Abstract][Full Text] [Related]
11. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.
McMullen JRW; Selleck M; Wall NR; Senthil M
Oncotarget; 2017 Jun; 8(26):43481-43490. PubMed ID: 28415645
[TBL] [Abstract][Full Text] [Related]
14. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.
Hayashi T; Yoshida Y; Yamada T; Tanaka K; Shimaoka H; Kajitani R; Munechika T; Nagano H; Matsumoto Y; Komono A; Sakamoto R; Aisu N; Yoshimatsu G; Yoshimura F; Hasegawa S
Cancer Med; 2022 Aug; 11(16):3126-3135. PubMed ID: 35312176
[TBL] [Abstract][Full Text] [Related]
15. Serum-Based KRAS
Kim JS; Bae GE; Kim SH; Choi MK; Yeo MK
Front Oncol; 2020; 10():604772. PubMed ID: 33585224
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival.
Baumgartner JM; Raymond VM; Lanman RB; Tran L; Kelly KJ; Lowy AM; Kurzrock R
Ann Surg Oncol; 2018 Aug; 25(8):2400-2408. PubMed ID: 29948422
[TBL] [Abstract][Full Text] [Related]
18. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
[TBL] [Abstract][Full Text] [Related]
19. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA.
Hussung S; Follo M; Klar RFU; Michalczyk S; Fritsch K; Nollmann F; Hipp J; Duyster J; Scherer F; von Bubnoff N; Boerries M; Wittel U; Fritsch RM
J Mol Diagn; 2020 Jul; 22(7):943-956. PubMed ID: 32376474
[TBL] [Abstract][Full Text] [Related]
20. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
